Mangoceuticals (MGRX) EBITDA Margin (2023 - 2026)
Mangoceuticals (MGRX) reported EBITDA Margin of -1095.01% for Q2 2026, up 1873.39 percentage points from -2968.40% a year earlier and up 3103.48 percentage points from the prior quarter.
Powered by 
Analysis
Mangoceuticals (MGRX) EBITDA Margin (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Mangoceuticals' EBITDA Margin came in at -3652.07%, down 1186.81 percentage points year-over-year; for FY2025, it came in at -3707.88%, down 2532.22 percentage points from FY2024.
- By year, EBITDA Margin came in at -1175.65% in FY2024 (+81.23 pp) and -1256.88% in FY2023.
- Five-year quarterly EBITDA Margin spans a low of -8953.15% in Q3 2025 and a high of -389.45% in Q4 2025.
- Year over year, EBITDA Margin gained in two of the last eight quarters, with an average year-over-year change of -1303.35 percentage points.
- The high point for year-over-year EBITDA Margin in five years was Q2 2026 (a gain of 1873.39 percentage points); the low point was Q3 2025 (a drop of 7637.53 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -4198.49% (Q1 2026), -389.45% (Q4 2025) and -8953.15% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 108.44 Bn | 104.53 Bn | - | 19.86% |
| 2 | Natera | 46.38 Bn | 42.00 Bn | 513.47 Mn | -5.84% |
| 3 | Labcorp Holdings | 30.37 Bn | 28.45 Bn | 1.11 Bn | 15.36% |
| 4 | Quest Diagnostics | 28.52 Bn | 26.28 Bn | 1.04 Bn | 20.21% |
| 5 | Tenet Healthcare | 23.21 Bn | 12.51 Bn | - | 35.02% |
| 6 | Guardant Health | 21.35 Bn | 16.97 Bn | 236.15 Mn | -33.96% |
| 7 | Tempus AI | 15.33 Bn | 12.48 Bn | 266.70 Mn | - |
| 8 | BrightSpring Health Services | 14.30 Bn | 12.05 Bn | 518.55 Mn | 4.78% |
| 9 | Encompass Health | 13.86 Bn | 13.49 Bn | - | 23.96% |
| 10 | Mangoceuticals | 3.37 Mn | 1.00 Mn | 44,215.00 | -1,095.01% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,095.01% |
| Mar 31, 2026 | -4,198.49% |
| Dec 31, 2025 | 338.63% |
| Sep 30, 2025 | -9,261.99% |
| Jun 30, 2025 | -2,884.59% |
| Mar 31, 2025 | -3,933.28% |
| Dec 31, 2024 | -1,593.78% |
| Sep 30, 2024 | -1,315.62% |
| Jun 30, 2024 | -1,329.13% |
| Mar 31, 2024 | -1,102.97% |
| Dec 31, 2023 | -1,048.29% |
| Sep 30, 2023 | -728.89% |
| Jun 30, 2023 | -1,618.58% |
| Mar 31, 2023 | -2,534.74% |
API Access
Mangoceuticals EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MGRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "MGRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MGRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();